Exelixis (EXEL)
(Delayed Data from NSDQ)
$23.70 USD
+0.17 (0.72%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $23.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Earnings News For EXEL
-
Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?
-
Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss
-
Exelixis: Q4 Earnings Snapshot
-
Exelixis (EXEL) Tops Q4 Earnings Estimates
-
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update
-
Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth
-
Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024
-
Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024
-
Exelixis (EXEL) Up 8.4% Since Last Earnings Report: Can It Continue?
-
Exelixis (EXEL) Q3 Earnings and Sales Miss, Annual View Updated
-
Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for
-
Why Is Exelixis (EXEL) Up 10.6% Since Last Earnings Report?
-
Exelixis (EXEL) Q2 Earnings Top, Cabometyx Drives Growth
-
Exelixis (EXEL) Tops Q2 Earnings and Revenue Estimates
-
Exelixis: Q2 Earnings Snapshot
-
Exelixis (EXEL) Reports Next Week: What You Should Expect
-
Why Is Exelixis (EXEL) Down 0.6% Since Last Earnings Report?
-
Exelixis (EXEL) Q1 Earnings Miss, Revenues Increase Y/Y
-
Exelixis: Q1 Earnings Snapshot
-
Exelixis (EXEL) Lags Q1 Earnings and Revenue Estimates
-
Exelixis (EXEL) Down 7.9% Since Last Earnings Report: Can It Rebound?
-
Exelixis (EXEL) Q4 Earnings Top, Revenues Beat on Cabometyx
-
Exelixis: Q4 Earnings Snapshot
-
Exelixis (EXEL) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for